Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. gained 0.850% compared to yesterday.
Our community is currently high on Prestige Consumer Healthcare Inc. with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 64 € shows a positive potential of 35.02% compared to the current price of 47.4 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 0.850% | -0.420% | -9.714% | -33.706% | -11.402% | -17.565% | 27.419% |
| Apollo Medical Holdings, Inc. | 0.000% | 5.128% | 17.143% | -16.892% | 16.038% | -32.044% | - |
| Petmed Express Inc | -2.650% | 0.405% | -7.506% | -25.498% | -31.254% | -86.038% | -92.614% |
| Suzuken Co Ltd | 1.270% | -4.790% | 0.633% | 27.200% | -3.049% | 27.200% | 0.633% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat